KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBT Margin: 2009-2025

Historic EBT Margin for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -2.09%.

  • Exact Sciences' EBT Margin rose 319.00% to -2.09% in Q3 2025 from the same period last year, while for Sep 2025 it was -32.28%, marking a year-over-year decrease of 2446.00%. This contributed to the annual value of -37.56% for FY2024, which is 2949.00% down from last year.
  • Exact Sciences' EBT Margin amounted to -2.09% in Q3 2025, which was down 29,600.57% from -0.01% recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' EBT Margin peaked at 0.17% during Q3 2023, and registered a low of -122.78% during Q4 2024.
  • Moreover, its 3-year median value for EBT Margin was -7.79% (2023), whereas its average is -17.82%.
  • As far as peak fluctuations go, Exact Sciences' EBT Margin surged by 4,228bps in 2021, and later slumped by 11,500bps in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' EBT Margin stood at -47.46% in 2021, then skyrocketed by 2,396bps to -23.50% in 2022, then skyrocketed by 1,571bps to -7.79% in 2023, then plummeted by 11,500bps to -122.78% in 2024, then spiked by 319bps to -2.09% in 2025.
  • Its EBT Margin stands at -2.09% for Q3 2025, versus -0.01% for Q2 2025 and -14.29% for Q1 2025.